← FDA Drug Approvals (Drugs@FDA)

NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE

NDA · New Drug Application · Sponsor: BAXTER HLTHCARE CORP · Approved 2021-01-15

Drug application

FDA Application #

NDA214313

Application type

New Drug Application

Brand name

NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE

Generic name

NOREPINEPHRINE BITARTRATE

Active ingredients

NOREPINEPHRINE BITARTRATE

Dosage form

SOLUTION

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

BAXTER HLTHCARE CORP

Manufacturer

Baxter Healthcare Corporation

First approval

2021-01-15

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown